Sandoval C, González B, Cheng S, Esquenazi Y, Mercado M

Language: Spanish
References: 10
Page: 459-464
PDF size: 175.74 Kb.

ABSTRACT

Background: Macroprolactinemia is defined as hyperprolactinemia with predominance of the big-big prolactine isoform. Its frequency has not been clearly established due to technical difficulties to identify it. This method used to detect it is gel filtration chromatography, an expensive and complicated procedure that could not be used routinely.
Objective: To validate the PEG precipitation technique, to identify the presence of macroprolactinemia and to correlate it with the clinical characteristics in a group of pre-selected patients with elevated serum PRL levels from different causes.
Patients and method: There were studied 14 patients non pre-selected with high PRL serum levels. Prolactine levels were determined with commercial immunometric quimioluminescence essays. All the essays were duplicated, and healthy patients serum (without hyperprolactinemia) were used. Technique consists on mixing 250 µL of serum with the same volume of polyethylene glycol. Later it was centrifugated at 3000 rpm during 30 minutes at 4°C. Prolactine level was measured in supernatant.
Results: Within patients 7 to 14 macroprolactinemia was ruled out and confirmed truth hyperprolactinemia, some times slight and nontumoral, some times mild, and some times due to prolactin-producer hypophysial macroadenomas.
Conclusions: Polyethylene glycol precipitation technique is reliable to detect macroprolactinemia.

REFERENCES

1. Sinha YN. Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 1995;16:354-69.

2. Hattori N, Inagaki C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL immunoglobulin G complex. J Clin Endocrinol Metab 1997;82:3107-10.

3. Vallete-Kasic S, Morange-Ramos I, Selim A, Gunz G, et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 2002;87:581-88.

4. Sam S, Molitch ME. The pituitary mass: diagnosis and management. Rev Endocr Metab Disord 2005;6:55-62.

5. Hattori N. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. J Clin Endocrinol Metab 1996;8:586-90.

6. Olukoga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol 1999;51:119-26.

7. Gibney J, Smith TP, McKenna TJ. Clinical relevance of macroprolactin. Clin Endocrinol 2005;62:633-43.

8. Fahie-Wilson MN, John R, Ellis AR. Macroprolactin: high molecular mass forms of circulating prolactin. Ann Clin Biochem 2005;42:175-92.

9. Huauche OM, Rocha AJ, Maia AC, Maciel RM, Viera JC. Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol 2002;57:327-31.

10. Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ. Gross variability in the detection of prolactin in sera containing bigbig prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 2002;87:5410-15.